MeSH D005764 - gastroesophageal reflux
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D015154:Esophageal motility disorders
0 Companies
0 Drugs
Success rate
D005764:Â
Gastroesophageal reflux
D057045:Laryngopharyngeal reflux
0 Companies
0 Drugs
Success rate
D000096663:Non-erosive reflux disease
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Metoclopramide | Reglan |  | 1983-03-25 |  |  |
| AbbVie | Famotidine | Famotidine |  | 2001-12-17 |  |  |
| Accord Healthcare | Esomeprazole | Esomeprazole |  | 2015-09-25 |  |  |
| Ajanta Pharma | Lansoprazole | Lansoprazole |  | 2016-10-14 |  |  |
| Naproxen, Esomeprazole strontium | Naproxen Esomeprazole Magnesium |  | 2022-10-06 |  |  | |
| Omeprazole | Omeprazole Bicarbonate |  | 2016-07-15 |  |  | |
| Ranitidine | Ranitidine |  | 2018-09-27 |  |  | |
| Pantoprazole | Pantoprazole |  | 2023-02-09 |  |  | |
| Famotidine | Famotidine |  | 2023-09-18 |  |  | |
| Akorn | Famotidine | Famotidine |  | 2014-05-30 |  |  |
| Alembic Pharmaceuticals | Famotidine | Famotidine |  | 2009-05-22 |  |  |
| Alkem Laboratories | Esomeprazole strontium | Esomeprazole Magnesium |  | 2017-10-20 |  |  |
| Famotidine, Ibuprofen | Ibuprofen Famotidine |  | 2021-08-03 |  |  | |
| Lansoprazole | Lansoprazole |  | 2019-01-18 |  |  | |
| Rabeprazole | Rabeprazole |  | 2018-04-24 |  |  | |
| Famotidine | Famotidine |  | 2022-01-07 |  |  |
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
50%10/20
Phase 2
83%15/18
Phase 3
65%32/49
Approved: 19Overall Success rate: 27%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
10
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use